ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression
ST. PETERSBURG, Fla., June 4, 2026 /PRNewswire/ -- ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, today announced the completion of a $200,000 seed raise. The raise will fund preclinical advancement of ARTAN Bio's proprietary engineered suppressor platform,...
ST. PETERSBURG, Fla., June 4, 2026 /PRNewswire/ -- ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, today announced the completion of a $200,000 seed raise. The raise will fund preclinical advancement of ARTAN Bio's proprietary engineered suppressor platform,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.